Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Eunkyung An"'
Autor:
Joon Seok Park, Wolyoung Kim, Eunkyung Kim, Hyaejung Hyun, Deokki Eom, Qingri Li, Yong Dae Shin, Jung Jaehyun, Sohee Im, Jae Hun Jung
Publikováno v:
Blood. 134:4426-4426
Introduction: Graft-versus-host-disease (GVHD) is a severe complication in patients undergoing hematopoietic stem cell transplantation (HSCT) and one of the major causes of death in patients receiving HSCT despite immunosuppressant drug and intensive
Autor:
Jung Lim Lee, Hyejoo Park, Hyun Jung Lee, Hyo Jung Kim, Kwang-Sung Ahn, Eunkyung Bae, Hwi-Joong Yoon, Sung-Soo Yoon, Daeyoon Kim, Chansu Lee, Youngil Koh
Publikováno v:
Blood. 126:4962-4962
Various factors released from BMSCs regulate the biologic behaviors of AML cells involving in responsiveness of chemotherapeutic treatment. Cytotoxic effect of Ara-C decreased when AML cells co-cultured with BMSCs. IL-6 expression was prominently inc
Autor:
Young Rok Do, Jee Hyun Kong, Yeung-Chul Mun, Jung Hye Kwon, Jooryung Huh, Yong Park, Sung Yong Oh, Sung Hwa Bae, Yang Soo Kim, Jae-Yong Kwak, Sang-wook Lee, Jong Ho Won, Hyo Jung Kim, Sun Ah Lee, Myung Hee Chang, Hwan Jung Yun, Soonil Lee, Jeong-A Kim, Hyun Jung Jun, Seok Jin Kim, Hye Jin Kang, Shin Kim, Eunkyung Park, Cheolwon Suh, Dok Hyun Yoon, Chan-Sik Park, Hyeon Seok Eom, Won Sik Lee, Je-Jung Lee, Jin Seok Kim, Jung Sun Park, Ji Hyun Park, Jae Hoon Lee, Min Kyoung Kim, Won Seog Kim
Publikováno v:
Blood. 124:4421-4421
Introduction Although several previous studies addressed the role of radiation in treating localized diffuse large B-cell lymphoma (DLBCL), chemotherapy alone has shown promising efficacy with the emergence of Rituximab. Thus, we evaluated the clinic
Autor:
Hyery Kim, Hyung Joon Kim, Ji Won Lee, Hee Young Shin, Eunkyung Kim, Hyoung Jin Kang, Kyung Duk Park, Hyo Seop Ahn
Publikováno v:
Blood. 122:1289-1289
Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signal transduction pathway integrating signals from multiple receptor tyrosine kinases has been firmly established as a major determinant for cell growth, proliferation, a
Autor:
Park, Hyejoo *, Kim, Daeyoon *, Lee, Chansu *, Bae, Eunkyung *, Ahn, Kwang-Sung *, Koh, Youngil *, Lee, Hyun Jung *, Kim, Hyo Jung *, Lee, Junglim, Yoon, Hwi-Joong, Yoon, Sung-Soo
Publikováno v:
In Blood 3 December 2015 126(23):4962-4962
Autor:
Inho Kim, Moon Hee Lee, Yeung-Chul Mun, Min Kyoung Kim, Hye Jin Kang, Yang Soo Kim, Hawk Kim, Young-Don Joo, Chang-Ki Min, Sang Min Lee, Sung-Soo Yoon, Jin Seok Kim, Jae Hoon Lee, Hyeon Seok Eom, Se-Ryeon Lee, Moo-Rim Park, Sung Hwa Bae, Sung-Hyun Kim, Kihyun Kim, Jae-Yong Kwak, Cheolwon Suh, Hoon-Gu Kim, Junshik Hong, June-Won Cheong, Jeong-A Kim, Eunkyung Park
Publikováno v:
Blood. 120:3106-3106
Abstract 3106 Background: Induction therapy followed by ASCT is the standard therapy for the newly diagnosed younger patients with MM. Recently, new drugs such as lenalidomide or bortezomib have shown the promising results as an induction treatment.
Autor:
Seok Kim, Yong Park, Jeong-A Kim, Hye Jin Kang, Soonil Lee, Yeung-Chul Mun, Eunkyung Park, Jae Hoon Lee, Won Seog Kim, Dok Hyun Yoon, Yang Soo Kim, Cheolwon Suh, Sun Ah Lee, Young Rok Do, Jong Ho Won, Won Sik Lee, Min Kyoung Kim, Sung Hwa Bae, Hyun Jung Jun, Hyo Jung Kim, Jee Hyun Kong, Jae-Yong Kwak, Sung Yong Oh, Hyeon Seok Eom, Je-Jung Lee, Jung Hye Kwon, Myung Hee Chang, Jin Seok Kim
Publikováno v:
Blood. 120:2683-2683
Abstract 2683 Background Secondary central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) includes CNS relapse or CNS involvement with systemic disease progression. Although many publications have provided information regar
Autor:
Yang Soo Kim, Jung Hye Kwon, Ho-Young Yhim, Jae-Yong Kwak, Jeong-A Kim, Hwi-Joong Yoon, Hyeon Seok Eom, Cheolwon Suh, Chang-Ki Min, Sung-Soo Yoon, Kihyun Kim, Jin Seok Kim, Yeung-Chul Mun, Sung Hwa Bae, Min Kyoung Kim, Hye Jin Kang, Eunkyung Park, Deok-Hwan Yang, Jae Hoon Lee, Ho Jin Shin
Publikováno v:
Blood. 118:1990-1990
Abstract 1990 Introduction: Autologous stem cell transplantation (ASCT) is a standard of care for younger multiple myeloma patients (pts). However, nearly all pts undergoing ASCT will relapse and require salvage therapy. Several investigators have re
Autor:
Sung Kyu Park, Ho Sup Lee, Sang Kyun Sohn, Won Seog Kim, Kyoung Ha Kim, Cheolwon Suh, Jong Ho Won, Sung Hwa Bae, Han Jo Kim, Chul Won Choi, Jae-Yong Kwak, Hye Jin Kang, Mark Hong Lee, Eunkyung Park, Jinny Park, Se Hyung Kim
Publikováno v:
Blood. 118:2021-2021
Abstract 2021 Background: High dose chemotherapy followed by autologous stem cell transplantation (ASCT) has become the standard approach for relapsed or high risk non-Hodgkin's lymphoma (NHL). Several different high dose therapy (HDT) conditioning r
Autor:
Hoon-Gu Kim, Chang-Ki Min, Sung-Soo Yoon, Moon Hee Lee, Sang Min Lee, June-Won Cheong, Hyeon Seok Eom, Yang Soo Kim, Kihyun Kim, Jae-Yong Kwak, Hye Jin Kang, Cheolwon Suh, Inho Kim, Jae Hoon Lee, Eunkyung Park, Moo-Rim Park, Hawk Kim, Jeong-A Kim, Sung Hwa Bae, Young-Don Joo, Yeung-Chul Mun, Se-Ryeon Lee, Sung-Hyun Kim, Jin Seok Kim, Min Kyoung Kim
Publikováno v:
Blood. 118:2044-2044
Abstract 2044 Background: Induction treatment followed by autologous stem cell transplantation (ASCT) is the standard therapy for the newly diagnosed younger patients with multiple myeloma (MM). Although new drugs such as lenalidomide or bortezomib h